Nicholas A. Meanwell

Author

Bristol-Myers Squibb (United States)ORCID

Also Known As

Meanwell, N.A., Meanwell, Nicholas, Meanwell, Nicholas A, Meanwell, Nicholas A., N A Meanwell, N Meanwell, N. A. MEANWELL, N. A. Meanwell, N. Meanwell, N.A. Meanwell

466

Publications

24.4K

Citations

H-Index

124

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (India)Biocon (India)

About

Nicholas A. Meanwell is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	109	9.9K
2	Natural Sciences	33	60	6.8K
3	Engineering	19	26	1K
4	Social Sciences	3	3	393
5	Allergy	1	1	54

Nicholas A. Meanwell

184

Publications

14.3K

Citations

H-Index

Page 1

	Year	Citations
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design Nicholas A. Meanwell Journal of Medicinal Chemistry Combinatorial ChemistryPharmaceutical ScienceRecent Tactical ApplicationAltmetric Attention ScorePharmacotherapy	2011	2.7K
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Min Gao, Richard E. Nettles, Makonen Belema, Nature Hcv Ns5a InhibitorViral HepatitisMedicineAntiviral Drug DevelopmentAntiviral Therapy	2010	929
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design Brett R. Beno, Kap‐Sun Yeung, Michael D. Bartberger, Journal of Medicinal Chemistry Pharmaceutical ScienceChemistryElectron DeficientPharmaceutical ChemistryMedicinal Chemistry	2015	743
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds Benjamin M. Johnson, Yue‐Zhong Shu, Xiaoliang Zhuo, Journal of Medicinal Chemistry	2020	633
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding Pin‐Fang Lin, Wade Blair, Tao Wang, Proceedings of the National Academy of Sciences ImmunologyMolecular BiologyImmunodominanceImmunotherapeuticsAntiviral Drug	2003	360
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels Valentin K. Gribkoff, John E. Starrett, Steven I. Dworetzky, Nature Medicine Cerebrovascular DiseaseSocial SciencesCerebral Vascular RegulationThrombosisHyperpolarization (Biology)	2001	308
Discovery of 4-Benzoyl-1-[(4-methoxy-1<i>H</i>- pyrrolo[2,3-<i>b</i>]pyridin-3-yl)oxoacetyl]-2- (<i>R</i>)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions Tao Wang, Zhongxing Zhang, Owen B. Wallace, Journal of Medicinal Chemistry Cd4-gp120 InteractionsPharmaceutical ScienceImmunologyPharmacotherapyDissolution-limited Absorption	2003	205
Identification of Hepatitis C Virus NS5A Inhibitors Julie A. Lemm, Donald R. O’Boyle, Mengping Liu, Journal of Virology	2009	193
Synthesis and Structure−Activity Relationships of 3-Aryloxindoles: A New Class of Calcium-Dependent, Large Conductance Potassium (Maxi-K) Channel Openers with Neuroprotective Properties Piyasena Hewawasam, Matthew Erway, Sandra L. Moon, Journal of Medicinal Chemistry Xenopus LaevisChemistryChemical BiologyLarge Conductance PotassiumHyperpolarization (Biology)	2002	185
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032) Fiona McPhee, Amy K. Sheaffer, Jacques Friborg, Antimicrobial Agents and Chemotherapy	2012	183

Page 1